Empowered Patient Podcast

Making Sense of Government Drug Discount Programs for Underserved Patients Subsidized by Drug Manufacturers with Jared Crapo Kalderos

Informações:

Synopsis

Jared Crapo, Head of Product and Technology at Kalderos, focuses on drug discounts paid by drug manufacturers to pharmacy benefit managers, commercial or government payers, and healthcare providers. Congress created the 340B Drug Discount Program and the Medicaid Drug Rebate Program to support healthcare for underserved patients. While these programs have dramatically grown, so too have the complexities and confusion about discounts and disagreements about payments. Jared explains, "The 340B program was created by Congress, and it's a subsidy from drug manufacturers to underserved healthcare providers. The Medicaid Drug Rebate Program is a similar program created by Congress that is a source of financial support for state Medicaid agencies, also provided by drug manufacturers. So drug manufacturers give a discount to state Medicaid agencies for drugs prescribed to Medicaid patients." "One way to think about it is there's a lot of information asymmetry, which means some stakeholders have access to a lot more